CNTF and amyotrophic lateral sclerosis: However, amyotrophic lateral sclerosis (ALS) trials with systemic CNTF injections were stopped due to unacceptable side effects (Miller et al., 1996), indicating that any manipulation of CNTF signaling in MN diseases will need to be more specifically targeted.